bioMérieux S.A.·Healthcare

Shares of bioMerieux (OTCMKTS:BMXMF - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $109.61, but opened at $115.00. bioMerieux shares last traded at $115.00, with a volume of 1,012 shares trading hands. Analysts Set New Price Targets Separately, BNP Paribas Exane cut shares of bioMerieux to

bioMérieux S.A. (BMXXY) Q4 2025 Earnings Call Transcript
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Healthcare
Medical - Diagnostics & Research
14,147
2017-09-21
0.67